NCT03630198View on ClinicalTrials.gov

Pain Outcomes Following Intralesional Corticosteroid Injections

PHASE4CompletedINTERVENTIONAL
Enrollment

31

Participants

Timeline

Start Date

October 1, 2018

Primary Completion Date

September 1, 2019

Study Completion Date

September 1, 2019

Conditions
KeloidAlopecia AreataAcneHypertrophic ScarEpidermal Inclusion CystFrontal Fibrosing AlopeciaLichen Plano-PilarisKeratoacanthomaPlaque PsoriasisLichen Simplex ChronicusPrurigo NodularisNummular EczemaGranuloma AnnulareMorpheaLichen Planus
Interventions
DRUG

Corticosteroid with lidocaine

Intralesional corticosteroid injection

DRUG

Corticosteroid with normal saline

Intralesional corticosteroid injection

Trial Locations (1)

37235

Vanderbilt University Medical Center, Nashville

All Listed Sponsors
lead

Vanderbilt University Medical Center

OTHER

NCT03630198 - Pain Outcomes Following Intralesional Corticosteroid Injections | Biotech Hunter | Biotech Hunter